0000004281-26-000012
SEC filingHowmet Aerospace Inc. (HWM) delivered strong FY 2025 financial performance with sales of $8.25B, operating income of $2.05B, and net income of $1.51B. Gross profit reached $2.82B after cost of goods sold of $5.43B, reflecting robust profitability in its aerospace components business. Key expenses included selling, general and administrative costs of $370.0M, R&D of $37.0M, depreciation and amortization of $283.0M, and restructuring charges of $84.0M. Interest expense net was $151.0M, with income taxes at $332.0M. Earnings per share stood at $4 basic and diluted, on 404.0M basic and 406.0M diluted shares. Balance sheet showed total assets of $11.18B, equity of $5.35B, and total liabilities of $5.83B, with cash at $742.0M and long-term debt of $2.86B. Operating cash flow was robust at $1.88B, supporting $700.0M stock repurchases and $181.0M dividends, while capex was $453.0M. Net cash increased $178.0M to $792.0M including restricted cash. This positions HWM with strong liquidity and shareholder returns amid aerospace demand.
Howmet Aerospace Inc. reported FY 2025 sales of $8.25B, up from prior periods though specific YoY not detailed here. Operating income was $2.05B after cost of goods sold $5.43B, SG&A $370.0M, R&D $37.0M, depreciation $283.0M, and restructuring $84.0M. Net income reached $1.51B following income before taxes of $1.84B, reduced by interest expense net $151.0M, debt redemption loss $15.0M, other expense $40.0M, and taxes $332.0M. EPS was $4 basic on 404.0M shares and $4 diluted on 406.0M shares. Total assets stood at $11.18B with equity $5.35B, reflecting retained earnings $4.09B offset by accumulated OCI loss -$1.67B. Cash flow from operations hit $1.88B, enabling significant capital allocation.
Sales totaled $8.25B for FY 2025 ending 2025-12-31. No segment breakdowns or geographic details are disclosed in the provided XBRL data. Revenue drivers not specified beyond total sales figure.
Gross profit calculated as $8.25B sales minus $5.43B COGS equals $2.82B, yielding gross margin of 34.2%. Operating margin on $2.05B operating income over $8.25B sales is 24.8%. Expenses structured with SG&A $370.0M (4.5% of sales), R&D $37.0M (0.4%), depreciation $283.0M (3.4%). No prior year margins for comparison provided.
Operating cash flow was $1.88B, driven by $1.51B net income plus $283.0M depreciation, $84.0M restructuring, stock comp $73.0M, offset by receivables increase $109.0M and inventories $50.0M. Capex $453.0M led to free cash flow of $1.88B - $453.0M = $1.43B. Financing used $1.27B including $700.0M stock repurchases, $181.0M dividends, net debt reduction. Investing outflow $438.0M. Balance sheet: cash $742.0M, current assets $3.78B, current liabilities $1.77B, long-term debt $2.86B, total liabilities $5.83B, equity $5.35B.
No management guidance, strategic priorities, or risk factors explicitly disclosed in the provided filing data.